You are here

MeiraGTx

Sanofi pays $30M for first look at MeiraGTx's data and a shot to brew up deals

Fierce Biotech

Tue, 10/31/23 - 09:25 pm

drug development

After $100M deal, J&J links gene therapy to improved vision in early-phase trial

Fierce Biotech

Mon, 10/3/22 - 10:11 am

clinical trials

retinal disease

X-linked retinitis pigmentosa

A busy year ahead for Parkinson’s disease

EP Vantage

Wed, 03/3/21 - 10:56 am

Parkinson's Disease

drug development

SAGE Therapeutics

J&J-partnered MeiraGTx aims at Biogen with new eye gene therapy data

Endpoints

Sat, 07/18/20 - 12:11 pm

Retinitis pigmentosa

clinical trials

3 Small-Cap Biotech Stocks That Soared Last Week

Motley Fool

Mon, 07/1/19 - 10:27 am

Dova Pharmaceuticals

Krystal Biotech

3 Biotech Stocks That Soared Last Week

Motley Fool

Sun, 05/19/19 - 04:02 pm

Adverum Biotechnologies

cervical cancer

Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout

Investors Business Daily

Fri, 05/17/19 - 07:14 pm

After J&J retinal deal, MeiraGTx raises $80M for unpartnered programs

BioCentury

Wed, 02/27/19 - 07:16 pm

retinal disease

J&J snags rights to a gene therapy portfolio from little MeiraGTx, a spinoff from Sam Waksal’s Kadmon

Endpoints

Thu, 01/31/19 - 11:46 am

Three Biotechs Announced IPOs Friday

BioSpace

Sun, 06/10/18 - 07:09 pm

Magenta Therapeutics